These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37355690)

  • 1. Schizophrenia-associated NRXN1 deletions induce developmental-timing- and cell-type-specific vulnerabilities in human brain organoids.
    Sebastian R; Jin K; Pavon N; Bansal R; Potter A; Song Y; Babu J; Gabriel R; Sun Y; Aronow B; Pak C
    Nat Commun; 2023 Jun; 14(1):3770. PubMed ID: 37355690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derived
    Pak C; Danko T; Mirabella VR; Wang J; Liu Y; Vangipuram M; Grieder S; Zhang X; Ward T; Huang YA; Jin K; Dexheimer P; Bardes E; Mitelpunkt A; Ma J; McLachlan M; Moore JC; Qu P; Purmann C; Dage JL; Swanson BJ; Urban AE; Aronow BJ; Pang ZP; Levinson DF; Wernig M; Südhof TC
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34035170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic spectrum of NRXN1 mono- and bi-allelic deficiency: A systematic review.
    Castronovo P; Baccarin M; Ricciardello A; Picinelli C; Tomaiuolo P; Cucinotta F; Frittoli M; Lintas C; Sacco R; Persico AM
    Clin Genet; 2020 Jan; 97(1):125-137. PubMed ID: 30873608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional impacts of NRXN1 knockdown on neurodevelopment in stem cell models.
    Zeng L; Zhang P; Shi L; Yamamoto V; Lu W; Wang K
    PLoS One; 2013; 8(3):e59685. PubMed ID: 23536886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incomplete penetrance of NRXN1 deletions in families with schizophrenia.
    Todarello G; Feng N; Kolachana BS; Li C; Vakkalanka R; Bertolino A; Weinberger DR; Straub RE
    Schizophr Res; 2014 May; 155(1-3):1-7. PubMed ID: 24680031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic regulation of Nrxn1 [corrected] expression: an integrative cross-species analysis of schizophrenia candidate genes.
    Mozhui K; Wang X; Chen J; Mulligan MK; Li Z; Ingles J; Chen X; Lu L; Williams RW
    Transl Psychiatry; 2011 Jul; 1(7):e25. PubMed ID: 22832527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.
    Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ
    Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prenatal diagnosis of partial deletion of NRXN1 gene with combined CNV-seq and qPCR assays].
    Wang L; Shi P; Ren H; Xue S; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1200-1204. PubMed ID: 36317203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precise Therapeutic Targeting of Distinct
    Fernando MB; Fan Y; Zhang Y; Kammourh S; Murphy AN; Ghorbani S; Onatzevitch R; Pero A; Padilla C; Flaherty EK; Prytkova IK; Cao L; Williams S; Fang G; Slesinger PA; Brennand KJ
    bioRxiv; 2023 Dec; ():. PubMed ID: 37961635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal impact of patient-specific aberrant NRXN1α splicing.
    Flaherty E; Zhu S; Barretto N; Cheng E; Deans PJM; Fernando MB; Schrode N; Francoeur N; Antoine A; Alganem K; Halpern M; Deikus G; Shah H; Fitzgerald M; Ladran I; Gochman P; Rapoport J; Tsankova NM; McCullumsmith R; Hoffman GE; Sebra R; Fang G; Brennand KJ
    Nat Genet; 2019 Dec; 51(12):1679-1690. PubMed ID: 31784728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical relevance of intragenic
    Cosemans N; Vandenhove L; Vogels A; Devriendt K; Van Esch H; Van Buggenhout G; Olivié H; de Ravel T; Ortibus E; Legius E; Aerssens P; Breckpot J; R Vermeesch J; Shen S; Fitzgerald J; Gallagher L; Peeters H
    J Med Genet; 2020 May; 57(5):347-355. PubMed ID: 31932357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.
    Gauthier J; Siddiqui TJ; Huashan P; Yokomaku D; Hamdan FF; Champagne N; Lapointe M; Spiegelman D; Noreau A; Lafrenière RG; Fathalli F; Joober R; Krebs MO; DeLisi LE; Mottron L; Fombonne E; Michaud JL; Drapeau P; Carbonetto S; Craig AM; Rouleau GA
    Hum Genet; 2011 Oct; 130(4):563-73. PubMed ID: 21424692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling Mechanisms of Patient-Specific NRXN1 Mutations in Neuropsychiatric Diseases Using Human Induced Pluripotent Stem Cells.
    De Los Angeles A; Tunbridge EM
    Stem Cells Dev; 2020 Sep; 29(17):1142-1144. PubMed ID: 32122280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence analysis of 17 NRXN1 deletions.
    Enggaard Hoeffding LK; Hansen T; Ingason A; Doung L; Thygesen JH; Møller RS; Tommerup N; Kirov G; Rujescu D; Larsen LA; Werge T
    Am J Med Genet B Neuropsychiatr Genet; 2014 Jan; 165B(1):52-61. PubMed ID: 24339137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1.
    Gregor A; Albrecht B; Bader I; Bijlsma EK; Ekici AB; Engels H; Hackmann K; Horn D; Hoyer J; Klapecki J; Kohlhase J; Maystadt I; Nagl S; Prott E; Tinschert S; Ullmann R; Wohlleber E; Woods G; Reis A; Rauch A; Zweier C
    BMC Med Genet; 2011 Aug; 12():106. PubMed ID: 21827697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders.
    Voineskos AN; Lett TA; Lerch JP; Tiwari AK; Ameis SH; Rajji TK; Müller DJ; Mulsant BH; Kennedy JL
    PLoS One; 2011; 6(6):e20982. PubMed ID: 21687627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of NRXN1 deletions: clinical and molecular characterization.
    Dabell MP; Rosenfeld JA; Bader P; Escobar LF; El-Khechen D; Vallee SE; Dinulos MB; Curry C; Fisher J; Tervo R; Hannibal MC; Siefkas K; Wyatt PR; Hughes L; Smith R; Ellingwood S; Lacassie Y; Stroud T; Farrell SA; Sanchez-Lara PA; Randolph LM; Niyazov D; Stevens CA; Schoonveld C; Skidmore D; MacKay S; Miles JH; Moodley M; Huillet A; Neill NJ; Ellison JW; Ballif BC; Shaffer LG
    Am J Med Genet A; 2013 Apr; 161A(4):717-31. PubMed ID: 23495017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single cell analysis of autism patient with bi-allelic NRXN1-alpha deletion reveals skewed fate choice in neural progenitors and impaired neuronal functionality.
    Lam M; Moslem M; Bryois J; Pronk RJ; Uhlin E; Ellström ID; Laan L; Olive J; Morse R; Rönnholm H; Louhivuori L; Korol SV; Dahl N; Uhlén P; Anderlid BM; Kele M; Sullivan PF; Falk A
    Exp Cell Res; 2019 Oct; 383(1):111469. PubMed ID: 31302032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression.
    Lowther C; Speevak M; Armour CM; Goh ES; Graham GE; Li C; Zeesman S; Nowaczyk MJ; Schultz LA; Morra A; Nicolson R; Bikangaga P; Samdup D; Zaazou M; Boyd K; Jung JH; Siu V; Rajguru M; Goobie S; Tarnopolsky MA; Prasad C; Dick PT; Hussain AS; Walinga M; Reijenga RG; Gazzellone M; Lionel AC; Marshall CR; Scherer SW; Stavropoulos DJ; McCready E; Bassett AS
    Genet Med; 2017 Jan; 19(1):53-61. PubMed ID: 27195815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the neurexin 1 gene is associated with schizophrenia.
    Rujescu D; Ingason A; Cichon S; Pietiläinen OP; Barnes MR; Toulopoulou T; Picchioni M; Vassos E; Ettinger U; Bramon E; Murray R; Ruggeri M; Tosato S; Bonetto C; Steinberg S; Sigurdsson E; Sigmundsson T; Petursson H; Gylfason A; Olason PI; Hardarsson G; Jonsdottir GA; Gustafsson O; Fossdal R; Giegling I; Möller HJ; Hartmann AM; Hoffmann P; Crombie C; Fraser G; Walker N; Lonnqvist J; Suvisaari J; Tuulio-Henriksson A; Djurovic S; Melle I; Andreassen OA; Hansen T; Werge T; Kiemeney LA; Franke B; Veltman J; Buizer-Voskamp JE; ; Sabatti C; Ophoff RA; Rietschel M; Nöthen MM; Stefansson K; Peltonen L; St Clair D; Stefansson H; Collier DA
    Hum Mol Genet; 2009 Mar; 18(5):988-96. PubMed ID: 18945720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.